Literature DB >> 15939723

Are drug eluting stents really worth the money?

M Thomas.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15939723      PMCID： PMC1860980          DOI： 10.1136/hrt.2005.066316

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  14 in total

1.  Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.

Authors:  Mandeep Singh; Bernard J Gersh; Robyn L McClelland; Kalon K L Ho; James T Willerson; William F Penny; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2005-01-18       Impact factor: 24.094

2.  Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents.

Authors:  Laura Mauri; E John Orav; A James O'Malley; Jeffrey W Moses; Martin B Leon; David R Holmes; Paul S Teirstein; Joachim Schofer; Günter Breithardt; Donald E Cutlip; Dean J Kereiakes; Chunxue Shi; Brian G Firth; Dennis J Donohoe; Richard E Kuntz
Journal:  Circulation       Date:  2005-01-17       Impact factor: 29.690

3.  Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study.

Authors:  A Bagust; A D Grayson; N D Palmer; R A Perry; T Walley
Journal:  Heart       Date:  2005-04-14       Impact factor: 5.994

4.  Economic evaluation of sirolimus-eluting stents.

Authors:  Fiona M Shrive; Braden J Manns; P Diane Galbraith; Merril L Knudtson; William A Ghali
Journal:  CMAJ       Date:  2005-02-01       Impact factor: 8.262

5.  One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  Circulation       Date:  2004-04-12       Impact factor: 29.690

6.  Procedural results and late clinical outcomes following multivessel coronary stenting.

Authors:  R Kornowski; R Mehran; L F Satler; A D Pichard; K M Kent; A Greenberg; G S Mintz; M K Hong; M B Leon
Journal:  J Am Coll Cardiol       Date:  1999-02       Impact factor: 24.094

7.  Predictive factors of restenosis after coronary stent placement.

Authors:  A Kastrati; A Schömig; S Elezi; H Schühlen; J Dirschinger; M Hadamitzky; A Wehinger; J Hausleiter; H Walter; F J Neumann
Journal:  J Am Coll Cardiol       Date:  1997-11-15       Impact factor: 24.094

8.  Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.

Authors:  David R Holmes; Martin B Leon; Jeffrey W Moses; Jeffrey J Popma; Donald Cutlip; Peter J Fitzgerald; Charles Brown; Tim Fischell; Shing Chiu Wong; Mark Midei; David Snead; Richard E Kuntz
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

9.  Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries.

Authors:  Ioannis Iakovou; Gary S Mintz; George Dangas; Alexandre Abizaid; Roxana Mehran; Alexandra J Lansky; Yoshio Kobayashi; Makoto Hirose; Dale T Ashby; Gregg W Stone; Jeffrey W Moses; Martin B Leon
Journal:  Am J Cardiol       Date:  2003-11-15       Impact factor: 2.778

10.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.

Authors:  Jeffrey W Moses; Martin B Leon; Jeffrey J Popma; Peter J Fitzgerald; David R Holmes; Charles O'Shaughnessy; Ronald P Caputo; Dean J Kereiakes; David O Williams; Paul S Teirstein; Judith L Jaeger; Richard E Kuntz
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245
View more
  1 in total

1.  Trends in hospital discharges, management and in-hospital mortality from acute myocardial infarction in Switzerland between 1998 and 2008.

Authors:  Charlène Insam; Fred Paccaud; Pedro Marques-Vidal
Journal:  BMC Public Health       Date:  2013-03-25       Impact factor: 3.295
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.